Thurston Springer Miller Herd & Titak’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Buy
4,202
+239
+6% +$27.6K 0.18% 142
2026
Q1
$474K Sell
3,963
-924
-19% -$121K 0.2% 137
2025
Q4
$665K Buy
4,887
+3,196
+189% +$460K 0.23% 108
2025
Q3
$249K Sell
1,691
-18,715
-92% -$2.6M 0.49% 53
2025
Q2
$2.64M Buy
20,406
+2,713
+15% +$329K 0.34% 77
2025
Q1
$2.11M Buy
17,693
+3,739
+27% +$463K 0.36% 76
2024
Q4
$1.62M Buy
13,954
+4,477
+47% +$566K 0.33% 75
2024
Q3
$1.28M Buy
9,477
+899
+10% +$120K 0.35% 71
2024
Q2
$1.16M Buy
+8,578
New +$1.17M 0.36% 69

Other funds holding XYL

Thurston Springer Miller Herd & Titak's XYL Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Xylem (XYL) stake by 6% in Q2 2026, buying an estimated $27.6K and bringing the position to 4,202 shares worth $497K. The position accounts for 0.18% of the portfolio, ranked #142.

Thurston Springer Miller Herd & Titak first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.64M in Q2 2025. 340 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 4,202 shares of Xylem worth $497K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 239 Xylem shares in Q2 2026, an estimated $27.6K.
  • Xylem made up 0.18% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #142 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's Xylem position peaked at $2.64M in Q2 2025.
  • 340 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.